Table 2.
Cases | E-DII quintiles | Ptrendc | |||||
---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | |||
Any adenoma | |||||||
E-DII from food and supplement | 1177 | Reference | 0.80 (0.66, 0.97) | 0.95 (0.79, 1.16) | 0.82 (0.67, 1.00) | 0.86 (0.69, 1.06) | 0.27 |
E-DII from food only | 1177 | Reference | 0.87 (0.72, 1.04) | 0.77 (0.63, 0.94) | 0.75 (0.60, 0.94) | 0.82 (0.64, 1.05) | 0.06 |
Advanced adenoma | |||||||
E-DII from food and supplement | 279 | Reference | 0.95 (0.64, 1.40) | 1.19 (0.79, 1.78) | 0.93 (0.61, 1.42) | 1.29 (0.83, 2.01) | 0.35 |
E-DII from food only | 279 | Reference | 1.50 (1.02, 2.20) | 0.94 (0.61, 1.45) | 1.03 (0.64, 1.66) | 1.30 (0.77, 2.18) | 0.95 |
Any recurrent adenoma | |||||||
E-DII from food and supplement | 895 | Reference | 1.08 (0.86, 1.32) | 1.23 (0.99, 1.53) | 1.16 (0.92, 1.42) | 1.63 (1.28, 2.03) | <0.001 |
E-DII from food only | 895 | Reference | 1.25 (1.03, 1.56) | 1.12 (0.90, 1.42) | 1.23 (0.96, 1.57) | 1.16 (0.90, 1.53) | 0.46 |
Advanced recurrent adenoma | |||||||
E-DII from food and supplement | 229 | Reference | 1.10 (0.72, 1.69) | 1.06 (0.67, 1.65) | 1.08 (0.70, 1.73) | 1.68 (1.05, 2.63) | 0.03 |
E-DII from food only | 229 | Reference | 1.20 (0.76, 1.79) | 1.10 (0.69, 1.72) | 1.27 (0.80, 2.03) | 0.95 (0.53, 1.66) | 0.96 |
Colorectal cancer | |||||||
E-DII from food and supplement | 1022 | Reference | 1.21 (0.99, 1.48) | 1.10 (0.89, 1.35) | 1.26 (1.03, 1.55) | 1.34 (1.09, 1.65) | 0.009 |
E-DII from food only | 1022 | Reference | 0.93 (0.76, 1.13) | 1.07 (0.88, 1.30) | 1.14 (0.94, 1.38) | 1.06 (0.86, 1.30) | 0.17 |
Proximal colorectal cancer | |||||||
E-DII from food and supplement | 601 | Reference | 1.02 (0.79, 1.33) | 0.89 (0.67, 1.17) | 1.22 (0.93, 1.61) | 0.99 (0.75, 1.29) | 0.69 |
E-DII from food only | 601 | Reference | 0.91 (0.70, 1.18) | 1.08 (0.83, 1.41) | 1.03 (0.79, 1.33) | 1.07 (0.81, 1.42) | 0.41 |
Distal colorectal cancer | |||||||
E-DII from food and supplement | 421 | Reference | 1.34 (0.97, 1.88) | 1.39 (1.00, 1.94) | 1.65 (1.19, 2.28) | 1.79 (1.28, 2.48) | <0.001 |
E-DII from food only | 421 | Reference | 1.05 (0.76, 1.49) | 1.38 (1.01, 1.90) | 1.44 (1.05, 1.97) | 1.43 (1.04, 1.97) | 0.006 |
E-DII Energy-Adjusted Dietary Inflammatory Index, NSAIDs non-steroidal anti-inflammatory drugs.
aAdjusted for age (continuous), energy intake (continuous), gender (male, female), body mass index (continuous), smoking status (current, former, never), alcohol drinking status (current, former, never), marital status (single, married, divorced or separated, widowed), educational level (less than high school, high school graduate or equivalent, post-high school education, college education or higher), physical activity (active less than one time per month, active at least one time per month), family history of colorectal cancer (yes, no) and NSAIDs use status (yes, no). Multivariable-adjusted Cox hazards regressions for colorectal cancer further adjusted trial arm (intervention group, control group).
bDQX was used to calculate E-DII scores for analyses on incident adenoma and recurrent adenoma, DHQ was employed for E-DII calculation on analyses of colorectal cancer.
cLinear trends across quintiles of E-DII scores were tested by modelling the median value in each quintile as a continuous variable in Cox regression.